Alzheimer’s research: Superspreader fibrils caught in the act

The treatment of dementia disorders such as Alzheimer’s is still one of the greatest challenges facing modern medicine. In the course of neurodegenerative diseases, certain proteins such as the amyloid β protein accumulate in the brain. They are suspected of being linked to the development of the disease, which is why they are considered a promising target for therapeutic approaches.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup